InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the full record of transactions filed by Schemel Donald Robert, 董事. Director active across 1 company, notably Panbela Therapeutics, Inc.. In total, 2 reports have been published. Breakdown: 1 buy · 0 sell. History available since 25 May 2021. The latest transaction was filed on 25 May 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Schemel Donald Robert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
200,000 股Common StockSEC:0001437749-22-023773:0
标准退出：2023年1月2日 (T+90)
4,316 股0Common StockSEC:0001437749-21-013594:0
2 条申报中的 2 条
About Schemel Donald Robert
Donald Robert Schemel is a Board Member at Panbela Therapeutics, Inc. He brings significant expertise in the biotechnology sector, contributing to the strategy and governance of the company. His role includes evaluating operational performance and guiding growth initiatives. He is committed to supporting innovation and improving services.
